☆ 4.6 Article

COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Rheumatology

COVID-19 in Italian patients with rheumatic autoimmune systemic diseases

Clodoveo Ferri et al.

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: a meta-analysis

Wen Wen et al.

Summary: This study conducted a meta-analysis on three new oral antivirals (molnupiravir, fluvoxamine, and Paxlovid) and their effects on mortality and hospitalization rates among COVID-19 patients. The results showed that these drugs were effective in reducing mortality and hospitalization rates by approximately 67%. Furthermore, the drugs did not increase adverse events, indicating good overall safety.

ANNALS OF MEDICINE (2022)

添加到收藏夹

Letter Rheumatology

Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2

Marcella Visentini et al.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Letter Rheumatology

Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases

Francesco Ursini et al.

CLINICAL RHEUMATOLOGY (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

COVID-19 Therapeutics for Nonhospitalized Patients

Rajesh T. Gandhi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Immunology

Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination

G. Fiorillo et al.

Summary: Vaccinations can trigger cutaneous small-vessel vasculitis, a condition that may be immune-mediated. This rare side effect is characterized by inflammation in the blood vessels of the skin and has been reported following the administration of certain vaccines.

JOURNAL OF AUTOIMMUNITY (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Inter net-Based Survey

Richard Tsai et al.

Summary: This study investigated COVID-19 vaccine hesitancy and acceptance among individuals with comorbid conditions. Significant vaccine hesitancy was found, and early self-reported side effect experiences among those who had already been vaccinated may help alleviate vaccine fears. Health care-related social media forums may play an important role in disseminating accurate information about COVID-19 vaccines.

JMIR PUBLIC HEALTH AND SURVEILLANCE (2022)

添加到收藏夹

Review Immunology

Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life

Laura Gragnani et al.

Summary: This study provides a detailed analysis of CV patients treated with DAA-based regimes and followed-up for more than 72 weeks. It identifies clinical and laboratory predictors of disease outcome and proposes two new scores, CV and Global Severity Index, as reliable tools for predicting CV clinical response. These findings can fill a gap in the clinical management of HCV-related CV.

AUTOIMMUNITY REVIEWS (2022)

添加到收藏夹

Review Infectious Diseases

First-generation oral antivirals against SARS-CoV-2

Parham Sendi et al.

Summary: This article provides an overview of first-generation oral antiviral agents against SARS-CoV-2, including the authorized use of molnupiravir, nirmatrelvir, and ritonavir. These drugs have shown some efficacy in non-hospitalized, mild-to-moderate COVID-19 patients at high risk for clinical progression. However, their use in clinical practice requires attention to factors such as timing of administration, drug-drug interactions, embryo-fetal toxicity, and compliance with pill ingestion. Knowledge gaps remain regarding the efficacy of these agents in vaccinated, hospitalized, or immunosuppressed individuals.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Review Rheumatology

COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations

Rebecca Grainger et al.

Summary: This review summarizes the current knowledge on SARS-CoV-2 infection, COVID-19 prevention and treatment in people with rheumatic disease. It suggests that rheumatic disease is associated with a slightly higher risk of SARS-CoV-2 infection, but outcomes of COVID-19 are influenced by comorbidities and specific disease states or treatments. Further research is needed to address the specific considerations for people with rheumatic disease.

NATURE REVIEWS RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination

Caoilfhionn M. Connolly et al.

Summary: Disease flares following 2-dose SARS-CoV-2 mRNA vaccination in patients with RMDs were uncommon, with no reports of severe flares. Injection site pain and fatigue were the most frequently reported reactions. Factors such as prior SARS-CoV-2 infection, flares in the preceding 6 months, and the use of combination immunomodulatory therapy were associated with flares.

ARTHRITIS & RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

Laura Boekel et al.

Summary: This study found that older patients with autoimmune diseases on specific immunosuppressive drugs may have delayed antibody development after the first COVID-19 vaccination. However, second or repeated exposure to SARS-CoV-2, either through infection or vaccination, can improve humoral immunity in these patients. Delaying the second dose of COVID-19 vaccines in patients receiving immunosuppressive drugs should be avoided, and future studies including younger patients are needed to confirm the generalizability of the results.

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Editorial Material Rheumatology

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases

Laura Boekel et al.

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jerome Avouac et al.

Summary: Rituximab therapy is associated with more severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases, and should be prescribed with caution.

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Article Immunology

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

Clodoveo Ferri et al.

Summary: This study found significantly lower NAbs levels and higher percentage of non-responders to COVID-19 vaccines among ASD patients. Early determination of serum NAb and prioritizing booster doses or different types of vaccines based on individual responses are recommended.

JOURNAL OF AUTOIMMUNITY (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Einav G. Levin et al.

Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Sex Differences on Clinical Characteristics, Severity, and Mortality in Adult Patients With COVID-19: A Multicentre Retrospective Study

Jing Sha et al.

Summary: The study found that age and sex have a significant interaction in COVID-19 in-hospital mortality, with male sex being an independent risk factor. While female mortality in COVID-19 is lower than male, it may not be directly related to the effect of estrogen. Further research is needed to identify sex differences and mechanisms involved in COVID-19.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Letter Rheumatology

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

Brian J. Boyarsky et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Letter Rheumatology

SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response

Michael Markus Bonelli et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Rheumatology

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

Ulf M. Geisen et al.

Summary: In this study, the efficacy and safety of anti-SARS-CoV-2 mRNA vaccines in immunosuppressed patients were compared with healthy controls. The results showed that all study participants developed antibodies, with lower IgG titres in patients compared to controls. Side effects were minimal and no disease flares were observed, demonstrating the efficiency and safety of mRNA vaccines in this cohort despite its small size.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Rheumatology

Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study

Youn Ho Shin et al.

Summary: In the early stages of the COVID-19 pandemic, autoimmune inflammatory rheumatic diseases were linked to a higher likelihood of testing positive for SARS-CoV-2, experiencing more severe COVID-19 outcomes, and facing COVID-19-related deaths in South Korea. High doses of systemic corticosteroids, but not DMARDs, were associated with negative effects on SARS-CoV-2 infection and COVID-19 clinical outcomes.

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Editorial Material Rheumatology

Cutaneous vasculitis following COVID-19 vaccination

Giulio Cavalli et al.

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Victoria Furer et al.

Summary: Vaccination with mRNA BNT162b2 vaccine showed reduced immunogenicity in patients with AIIRD compared to the general population, with risk factors including older age and treatment with glucocorticoids, rituximab, mycophenolate mofetil (MMF), and abatacept. However, most patients maintained stable disease activity post-vaccination.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Rheumatology

Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2

Yolanda Braun-Moscovici et al.

Summary: The vast majority of patients with inflammatory rheumatic diseases developed a significant humoral response following the administration of the second dose of the Pfizer mRNA vaccine against SARS-CoV-2 virus. Only minor side effects were reported and no apparent impact on IRD activity was noted.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Letter Rheumatology

High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases

Jake A. Ruddy et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Correction Rheumatology

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV brasil registry (vol 7, e001461, 2021)

C. D. L. Marques et al.

RMD OPEN (2021)

添加到收藏夹

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

添加到收藏夹

Article Microbiology

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Alexander E. Gorbalenya et al.

NATURE MICROBIOLOGY (2020)

添加到收藏夹

Article Rheumatology

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Milena Gianfrancesco et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Article Rheumatology

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Jose L. Pablos et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Article Rheumatology

Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Dalifer D. Freites Nunez et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Rheumatology

COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series

Clodoveo Ferri et al.

CLINICAL RHEUMATOLOGY (2020)

添加到收藏夹

Review Rheumatology

Cryoglobulinemia: An update in 2019

Anne Claire Desbois et al.

JOINT BONE SPINE (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis

L. Gragnani et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

添加到收藏夹

Review Medicine, General & Internal

Human autoimmune diseases: a comprehensive update

Lifeng Wang et al.

JOURNAL OF INTERNAL MEDICINE (2015)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer

Clodoveo Ferri et al.

WORLD JOURNAL OF HEPATOLOGY (2015)

添加到收藏夹

Article Rheumatology

Validation of the classification criteria for cryoglobulinaemic vasculitis

Luca Quartuccio et al.

RHEUMATOLOGY (2014)

添加到收藏夹

Article Immunology

B-cells and mixed cryoglobulinemia

Clodoveo Ferri et al.

AUTOIMMUNITY REVIEWS (2007)

添加到收藏夹

Review Rheumatology

Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients

C Ferri et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)

添加到收藏夹

Review Pathology

Cryoglobulins

C Ferri et al.

JOURNAL OF CLINICAL PATHOLOGY (2002)

添加到收藏夹

Article Medicine, General & Internal

Cryoglobulinemia -: Study of etiologic factors and clinical and immunologic features in 443 patients from a single center

O Trejo et al.

MEDICINE (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.